Clinical Trials
66 trialsOCTANE
University Health Network, Toronto
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LEARN
University of Sydney
OvAR-Y
Washington University School of Medicine
SHERLOCK
University Health Network, Toronto
iCaRe2
University of Nebraska
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Evaluation of Improved Onboard Patient Imaging
Varian, a Siemens Healthineers Company
TraveraRTGx
Travera Inc
MOMENTUM
UMC Utrecht
QVA-Mod
Hospices Civils de Lyon
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
PETRiS
XEOS Medical
LIBERATE
University Health Network, Toronto
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
Kansas State University
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Serpentine
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
PREFER
Labcorp Corporation of America Holdings, Inc
MOM
Inova Health Care Services
FUTURE
Assistance Publique Hopitaux De Marseille
MOHCCN-O
University Health Network, Toronto
Improving Evidence-Based Care for Cancer Patients
Medical University of South Carolina
ROOT
Taproot Health
Survivorship
University of Modena and Reggio Emilia
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
QUANTUM
VitaMed Research LLC
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
POSITive
European Institute of Oncology
A Follow-up Study of Women Evaluated and Treated for Infertility
National Institutes of Health Clinical Center (CC)
Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample
Stanford University
The Development of Quantitative Ultrasound Imaging Software Platform
Seoul National University Bundang Hospital
Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies
Sunnybrook Health Sciences Centre
G-DEFINER
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
WiZen
Technische Universität Dresden
DETECT
Boryung Pharmaceutical Co., Ltd
PIONEER
SpeciCare
The Frequency of Thyroid Diseases in Women With Breast Cancer
UÅŸak University
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
National Institutes of Health Clinical Center (CC)
The Incidence of Breast and Other Cancers Among Female Flight Attendants
National Institutes of Health Clinical Center (CC)
EPR Tumor Oximetry With CE India Ink
Dartmouth-Hitchcock Medical Center
Study to Evaluate the Safety of Nanoxel M Inj.
Samyang Biopharmaceuticals Corporation
ANCERS-2
Mitra RxDx, Inc.
N1
CureOne
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)